Clinical Trials Browser

Phase 2 × OTHER_GOV × veliparib × Clear all

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

Phase 2 Completed

Testicular Neoplasms